Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Drug Resistance

Free Subscription 12.10.2026 1 Am J Trop Med Hyg 12 Antimicrob Agents Chemother 1 Infect Control Hosp Epidemiol 2 Int J Antimicrob Agents 2 J Antimicrob Chemother 1 PLoS Genet 3 PLoS One 1 Sex Transm Infect

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Trop Med Hyg

1. ROMAINA CACHIQUE L, Schiaffino F, Paredes Olortegui M, Manzanares K, et al
   Phenotypic Resistance of Campylobacter Isolates to an Extended Panel of Antibiotics.
   Am J Trop Med Hyg. 2026;115:711-714.
   PubMed         Abstract available
   
   

   
   Antimicrob Agents Chemother

2. PEREZ-RODRIGUEZ G, Gonzalez-Pinto L, Aja-Macaya P, Molina-Caceres C, et al
   In vivo emergence of ceftazidime/avibactam resistance in Pseudomonas aeruginosa driven by OXA-1381, a novel W157L Omega-loop variant of OXA-2.
   Antimicrob Agents Chemother. 2026;70:e0058426.
   PubMed         Abstract available
   
   
3. CHEN M, Zhi Q, Luo M, Lin M, et al
   IS26-mediated circular bla(KPC) transposon in ST2483 Pseudomonas aeruginosa.
   Antimicrob Agents Chemother. 2026;70:e0058226.
   PubMed         Abstract available
   
   
4. YANQING Z, Gaoyuan P, Xiaofeng P, Chaojuan L, et al
   Comparative transcriptome and proteome analysis of resistant and susceptible Talaromyces marneffei clinical isolates reveals a systemic multitiered defense network against azoles.
   Antimicrob Agents Chemother. 2026;70:e0029326.
   PubMed         Abstract available
   
   
5. WIEDERHOLD NP, Bisson C, Stevens DA, Hung C-Y, et al
   In vitro activity profiles and temporal trends in reduced susceptibility to azoles in Coccidioides in the United States.
   Antimicrob Agents Chemother. 2026;70:e0074426.
   PubMed         Abstract available
   
   
6. HAN C, Patel K, Gao H, Sanborn JT, et al
   Phage-first treatment results in subpopulation-driven collateral sensitivity to beta-lactams in an extensively drug-resistant Pseudomonas aeruginosa.
   Antimicrob Agents Chemother. 2026;70:e0004826.
   PubMed         Abstract available
   
   
7. GARAI P, Nozick SH, Jozefczyk CC, Nam H, et al
   L2 beta-lactamase contributes to ceftolozane-tazobactam resistance in Pseudomonas aeruginosa.
   Antimicrob Agents Chemother. 2026;70:e0035626.
   PubMed         Abstract available
   
   
8. CASTANHEIRA M, Kimbrough JH, Karr M, Sader HS, et al
   Impact of PBP3 insertions and beta-lactamase-encoding genes on the susceptibility of Escherichia coli isolates belonging to high-risk clones against aztreonam-avibactam and comparator agents.
   Antimicrob Agents Chemother. 2026;70:e0012926.
   PubMed         Abstract available
   
   
9. BRITT NS, Khader K, He T, Potter EM, et al
   Comparative effectiveness of ceftolozane/tazobactam relative to ceftazidime/avibactam for the treatment of adult, hospitalized patients with pneumonia due to multidrug-resistant Pseudomonas aeruginosa in U.S. Veterans Health Administration facilities.
   Antimicrob Agents Chemother. 2026;70:e0070726.
   PubMed         Abstract available
   
   
10. NAIR N, Sangal A, Kim S, Bayer I, et al
    Rapid broad-spectrum activity of molecular iodine against multidrug-resistant bacterial and fungal pathogens without residual staining.
    Antimicrob Agents Chemother. 2026;70:e0076426.
    PubMed         Abstract available
    
    
11. PITOUT JDD, Peirano G, Matsumura Y, Kock M, et al
    Escherichia coli with penicillin-binding protein 3 insertions: implications for newer beta-lactam/beta-lactamase inhibitor combinations.
    Antimicrob Agents Chemother. 2026;70:e0107726.
    PubMed         Abstract available
    
    
12. RODRIGUEZ-COELLO A, Outeda-Garcia M, Garcia-Pose A, Gonzalez-Pinto L, et al
    In vivo efficacy of cefiderocol against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa carrying the AmpC E219K substitution.
    Antimicrob Agents Chemother. 2026;70:e0072426.
    PubMed         Abstract available
    
    
13. GROSSMAN NT, Casadevall A
    Amphotericin B resistance in Lomentospora prolificans is associated with a soluble cell wall component.
    Antimicrob Agents Chemother. 2026;70:e0091526.
    PubMed         Abstract available
    
    

    
    Infect Control Hosp Epidemiol

14. VIANA-CARDENAS E, Jiang M, Rodriguez-Nava G, Tariq W, et al
    Hospital wastewater-based antimicrobial resistance epidemiology: a scoping review.
    Infect Control Hosp Epidemiol. 2026 Oct 9:1-12. doi: 10.1017/ice.2026.10558.
    PubMed         Abstract available
    
    

    
    Int J Antimicrob Agents

15. AIHARA M, Gotoh Y, Nakamura K, Kimura-Hyoda T, et al
    In reply to the Letter to the Editor regarding 'Stepwise within-host evolution of a bla(CTX-M-27)-positive Klebsiella pneumoniae clone under changing antimicrobial pressures leading to enhancement of beta-lactam resistance'.
    Int J Antimicrob Agents. 2026 Oct 5:108031.
    PubMed        
    
    
16. YUAN J, Wang H, Zhang X, Xie F, et al
    Ceftazidime-avibactam for the treatment of infections caused by carbapenem-resistant Gram-negative pathogens in Chinese patients: A phase IV, multi-center, open?label study.
    Int J Antimicrob Agents. 2026 Oct 3:108030.
    PubMed         Abstract available
    
    

    
    J Antimicrob Chemother

17. BAKTHAVATCHALAM YD, Rupali P, John J, Walia K, et al
    Beyond susceptibility: pharmacokinetic and pharmacodynamic constraints of existing oral antibiotics in extensively drug-resistant typhoid fever.
    J Antimicrob Chemother. 2026;81:dkag332.
    PubMed         Abstract available
    
    
18. SUN X, Lu W, Ge H, Qin Y, et al
    Tigecycline displays bactericidal activity against multidrug-resistant Neisseria gonorrhoeae and enhances clearance from a mouse infection model.
    J Antimicrob Chemother. 2026;81:dkag337.
    PubMed         Abstract available
    
    

    
    PLoS Genet

19. COLAUTTI J, Anderson AC, Clark WPK, Marmont LS, et al
    Altered regulation of septal peptidoglycan synthesis modulates beta-lactam susceptibility in Pseudomonas aeruginosa.
    PLoS Genet. 2026;22:e1012319.
    PubMed         Abstract available
    
    

    
    PLoS One

20. ABBAS M, Fattouh N, Chedraoui C, El Hachem S, et al
    Diverse genetic pathways drive convergent fluconazole and caspofungin resistance phenotypes in Candida albicans.
    PLoS One. 2026;21:e0360234.
    PubMed         Abstract available
    
    
21. POLLOCK J, Foster G, Maliska J, Henderson K, et al
    Characterisation of multidrug-resistant, avian pathogenic-like Escherichia coli O78 from dairy-bred calves with atypical colisepticaemia.
    PLoS One. 2026;21:e0359646.
    PubMed         Abstract available
    
    
22. TSUTSUNAVA A, Tukvadze N, Avaliani Z, Goig GA, et al
    Associating Mycobacterium tuberculosis genomic variants with minimum inhibitory concentrations to delamanid and pretomanid.
    PLoS One. 2026;21:e0359717.
    PubMed         Abstract available
    
    

    
    Sex Transm Infect

23. PINTO M, Ramos D, Rodrigues J, Matias R, et al
    Neisseria gonorrhoeae antimicrobial resistance trends in Portugal over four decades, 1983-2025.
    Sex Transm Infect. 2026 Oct 8:sextrans-2026-057131.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum